Abstract
Objective Infectious diseases are common but are not easily or readily diagnosed with current methodologies. This problem is further exacerbated with the constant presence of mutated, emerging, and novel pathogens. One of the most common sites of infection by many pathogens is the human throat. Yet, there is no universal diagnostic test that can distinguish these pathogens. Metatranscriptomic (MT) analysis of the throat represents an important and novel development in infectious disease detection and characterization, as it is able to identify all pathogens in a fully unbiased approach.
Design To test the utility of an MT approach to pathogen detection, throat samples were collected from participants before, during, and after an acute sickness.
Results Clear sickness-associated shifts in pathogenic microorganisms are detected in the participants along with important insights into microbial functions and antimicrobial resistance genes.
Conclusions MT analysis of the throat represents an effective method for the unbiased identification and characterization of pathogens. Since MT data include all microorganisms in the sample, this approach should allow for not only the identification of pathogens, but also an understanding of the effects of the resident throat microbiome in the context of human health and disease.
Competing Interest Statement
All authors are current or former employees of Viome, Inc. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
Funding Statement
This study was funded by Viome Life Sciences
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Viome IRB of Viome Life Sciences gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
